N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

Sponsor: Nadine Jackson, MD, MPH • ClinicalTrials.gov ID: NCT05375643

Registry updated: 2026-09-16
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

SURGE aims to increase representation in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.

Interventions

  • SURGE (Behavioral)
    Video with or without person to person guidance to support decision making around genetic testing

Eligibility criteria

Inclusion Criteria: * Adult (age 18 years or older) * Scheduled for a new patient consultation * Suspected or confirmed advanced malignancy (requiring active treatment) * DFCI patient at Longwood/Chestnut Hill, DFCI satellite at BMC-Brighton (formerly St. Elizabeth's Medical Center), DFCI satellite at Foxborough, or DFCI satellite at Merrimack Valley Exclusion Criteria: * Malignancy or former malignancy that requires only surveillance * Not continuing care at a participating DFCI site * Speaks a language other than English, Spanish, Haitian Creole, Russian, Portuguese, Arabic, or Traditional Chinese * Unable to provide consent

Conditions

Gastrointestinal Cancer Hematologic Cancer Thoracic Cancer

Locations

  • Dana Farber Cancer Institute — Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute at St. Elizabeth's Medical Center — Brighton, Massachusetts, United States
  • Dana-Farber Cancer Instiute - Merrimack Valley — Methuen, Massachusetts, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record